Evidio Domingo‐Musibay

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Amod A. Sarnaik, Omid Hamid, Nikhil I. Khushalani et al. · Journal of Clinical Oncology · 2021 · 373 citations · Full text

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

Jason Chesney, Karl D. Lewis, Harriet M. Kluger et al. · Journal for ImmunoTherapy of Cancer · 2022 · 268 citations · Full text

Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients

Can Özütemiz, Luke A. Krystosek, An Church et al. · Radiology · 2021 · 160 citations · Full text

Vaccination, Vaccine Safety, Unnecessary Biopsy +12

Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma

Evidio Domingo‐Musibay, Paari Murugan, Alessio Giubellino et al. · Journal for ImmunoTherapy of Cancer · 2018 · 70 citations · Full text

Long-term follow up of lifileucel (LN-144) cryopreserved autologous tumor infiltrating lymphocyte therapy in patients with advanced melanoma progressed on multiple prior therapies.

Amod A. Sarnaik, Nikhil I. Khushalani, Jason Chesney et al. · Journal of Clinical Oncology · 2020 · 37 citations

Immunology, Autologous Tumor, Immunotherapeutics +18